Issue - meetings
****
Meeting: 02/05/2023 - Risk, Audit and Performance Committee (Item 8)
8 Strategic Plan 2022-2025: Delivery Plan Quarter 4 Update - HSCP.23.028 PDF 241 KB
Additional documents:
- HSCP.23.028 App A Delivery Plan Quarterly version. Q4 Mar 2023, item 8 PDF 117 KB
- HSCP.23.028 App B Dashboard Development Plan Reporting FY 2023 Q4, item 8 PDF 777 KB
- HSCP.23.028_Appendix C_Strategic Framework Y2 Refresh, item 8 PDF 302 KB
Decision:
The Committee resolved:-
(i) to instruct the Strategy and Transformation Lead to provide a report to the Committee in June 2023 in respect of the Mental Health/ Learning Disability Portfolio Board and its progress;
(ii) to instruct the Strategy and Transformation Lead to provide a report to the Committee in respect of the Frailty Pathway Performance;
(iii) to note the Delivery Plan Quarter 4 Update and Dashboard as appended to the report at appendices a and b respectively; and
(iv) to note the performance framework which had been refreshed for 2023-24 in line with Year 2 of the Delivery Plan at appendix c of the report.
Minutes:
The Committee had before it a report providing assurance relating to progress of the Delivery Plan as set out within the Aberdeen City Health and Social Care Partnership (ACHSCP) Strategy Plan 2022-2025.
Michelle Grant - Transformation Programme Manager - Digital and Data, presented the report and responded to questions from Members
The report recommended:-
that the Committee:
(a) note the Delivery Plan Quarter 4 Update and Dashboard as appended to the report at appendices a and b respectively; and
(b) note the performance framework which had been refreshed for 2023-24 in line with Year 2 of the Delivery Plan at appendix c of the report.
The Committee resolved:-
(i) to instruct the Strategy and Transformation Lead to provide a report to the Committee in June 2023 in respect of the Mental Health/ Learning Disability Portfolio Board and its progress;
(ii) to instruct the Strategy and Transformation Lead to provide a report to the Committee in respect of the Frailty Pathway Performance; and
(iii) to otherwise approve the recommendations.